Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Optimal Iodine Supplementation During Antithyroid Drug Therapy for Graves’ Disease Is Associated With Lower Recurrence Rates Than Iodine Restriction
source: Clinical Endocrinology
authors: Huang H, Shi Y, Liang B, Cai H, Cai Q, Lin Rsummary/abstract:
A relationship between iodine intake and the effectiveness of antithyroid drug (ATD) therapy for Graves’ disease (GD) has been suggested, and strict restriction of iodine intake has been tried in the treatment of GD in some studies. However, it is unclear whether dietary iodine supplementation improves the prognosis of ATD therapy for GD. This study aimed to clarify whether optimal iodine supplementation during antithyroid drug therapy for GD is associated with lower recurrence rates than iodine restriction.
This was a prospective randomized trial of newly diagnosed patients with GD. Patients with newly diagnosed GD were recruited. After ATD therapy and strict dietary iodine restriction for 1 month, patients (n = 459) were randomly assigned to iodine-supplemented and iodine-restricted groups. After exclusion, 405 patients finally completed the study. The iodine-supplemented group included 203 patients (61 males and 142 females) with an average age of 32.2 ± 10.5 years (17-65 years), and the iodine-restricted group included 202 patients (61 males and 141 females) with an average age of 31.9 ± 11.8 years (16-64 years). Patients in the iodine-supplemented group were given about 10 grams of iodized salt every day, while the iodine-restricted group received noniodized salt with low-iodine or noniodine diet. The dietary iodine intervention lasted for 24 months. Urinary iodine concentration (UIC), thyrotropin receptor antibody (TRAb), free T3 (FT3), free T4 (FT4) and thyrotropin (TSH) of 2 groups were measured every 3 months. The recurrence rates within 12 months after withdrawal of ATD were evaluated.
UIC in the iodine-supplemented group was within the recommended range for optimal iodine intake (135-162 μg/L) and was significantly higher than that in iodine-restricted group (30-58 μg/L). Within 12 months of withdrawal of ATD, the total recurrence rate in the iodine-supplemented group was 35.5%, significantly lower than in the iodine-restricted group, which was 45.5%.
Optimal dietary iodine supplementation during antithyroid drug therapy for GD is associated with lower recurrence rates than iodine restriction, and therefore, diet control with strict iodine restriction might be an adverse factor in the management of GD.
read more full text
Hyperthyroidism: Should I Use Antithyroid Medicine or Radioactive Iodine?You may want to have a say in this decis...
Graves’ Disease Treatment for Someone in Their 20sHyperthyroidism triggered by Graves’ d...
Most Graves’ Disease Treated With Antithyroid DrugsAdults with Graves’ disease are more l...
Effects of Treatment Modalities for Graves’ Hyperthyroidism on Graves’ Orbitopathy: A 2015 Italian Society of En...Graves’ disease is the most frequent f...
Stress Triggers the Onset and the Recurrences of Hyperthyroidism in Patients With Graves’ DiseaseThe aim of this study was to evaluate th...
Relation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
Current Trends in Antithyroid Drug Treatment of Graves’ DiseaseIntroduction: Graves' hyperthyroidism i...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.